|Bid||0.0200 x 0|
|Ask||0.0220 x 0|
|Day's range||0.0200 - 0.0220|
|52-week range||0.0200 - 0.0740|
|Beta (5Y monthly)||2.18|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Bionomics Limited Unsponsored ADR (BNOX) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Bionomics ( ASX:BNO ) First Half 2023 Results Key Financial Results Net loss: AU$16.2m (loss widened by 24% from 1H...
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...